A double blind trial on a selected group of 125 adult patients investigated the effect of atropine in premedication.
INTRODUCTION
Atropine premedication, together with a narcotic or sedative, is widely used before general anaesthesia. The rationale behind the routine administration of belladonna-like substances is surprisingly poorly documented, perhaps because it is a tradition handed down from the early days of anaesthesia. The generally accepted reasons for using atropine and its analogues are prevention of vagal action on the heart, drying of salivary and bronchial secretions, and minimizing post-operative vomiting. It has been suggested that there may be contraindications to the routine administration of atropine, including excessive drying of secretions (Burton 1962) , increasing pulmonary dead space (Tonkin, Conway and Payne 1964, Conway and Payne 1966) , hyperpyrexia and unwanted tachycardia. Apart from these complications, proof is lacking that atropine premedication is in fact necessary for routine anaesthesia.
The effect of premedication with and without atropine was investigated by means of a doubleblind trial conducted on selected groups totalling 125 patients. Electrocardiograph changes from induction to maintenance of anaesthesia were compared. An assessment was made of the incidence of troublesome salivary secretions, coughing, vomiting and laryngeal spasm during induction and recovery. Intraoperative complications associated with premedication were compared between the groups.
METHOD
The trial included all routine adult anaesthetics given by the author during a period of three months, except (a) those patients having intraorbital operations and intraoral procedures such as oesophagoscopy, bronchoscopy and laryngoscopy;
(b) the very ill;
(c) those with established cardiac arrhythmias.
Two premedicants were used, both containing pethidine 100 mg and promethazine 25 mg. One also contained atropine 0·6 mg. The solutions were prepared in identical 1·0 ml ampoules, distributed in the order given by tables of random numbers. The key to the contents remained known only to the hospital pharmacy until all the information was collated. The premedication was ordered by number, the dose according to body weight-under 40 kg body weight 0·5 ml, betweenAO and 60 kg body weight 0'75ml, and over 60 kg l·Oml.
The premedication was given by the nursing staff approximately one hour prior to the commencement of surgery.
An ECG backplate (Telectronics) containing the four limb leads was placed under the patient's back immediately after the patient was moved on to the operating table and before induction. The leads were attached to an ECG monitor (Telectronics Cardiac Monitor model HS4) and ECG writer (Cardiotrace).
Recording commenced immediately, generally using standard lead 2, but occasionally using the other standard leads if interference was present. Recording ceased once the patient was stabilized and monitoring with the oscilloscope continued throughout the procedure. The time of intubation was marked on the paper strip. Three methods of induction of anaesthesia were used:
thiopentone-suxamethonium -intubation, thiopentone -pancuronium-intubation or thiopentone -halothanenitrous oxide-oxygen without intubation.
During induction any excessive salivation, laryngeal spasm, coughing or vomiting was recorded.
Following operation, the same parameters were again noted by the recovery room nursing staff until the patient was awake and ready to return to the ward. These complications were recorded as either present or absent. Any problems which occurred during the operation and which might be related to the premedication was also recorded. 
RESULTS
In this series of 125 patients, 51 received atropine and 74 did not. Ages ranged from 14 to 89. There was no significant difference in age or sex distribution between the two groups. The operations ranged from minor gynaecological to major thoracic procedures.
Cardiac Arrhythmias
The normal ECG was taken as sinus rhythm at rates between 60 and 150. Arrhythmias were subdivided into supraventricular and ventricular (Table 1) . The arrhythmias most commonly seen were unifocal ventricular premature beats and bigeminy, sinus tachycardia and nodal rhythm. On a number of occasions, arrhythmias were noted to occur only with laryngoscopy and intubation ( the arrhythmias gave cause for alarm. There was no significant difference in the incidence of arrhythmias between the atropine and the non-atropine groups.
Induction Problems
Only two patients, neither having atropine, presented any problems during induction. Both coughed and developed laryngeal spasm. One, 
Post-operative Problems
Curarized patients who received atropine and prostigmine were excluded from this part of the survey. Post-operative problems were uncommon (Table 3 ). There was no significant difference between the atropine and non-atropine groups.
Intra-operative Problems
A bradycardia of less than 50/min developed in five out of the 74 non-atropine group. Atropine 0·6 mg intravenously readily reversed the bradycardia, and this was not associated with any arrhythmias. Bradycardia did not occur in the atropine group. There was no statistical difference in the two groups (p >0 '05). No other problems related to premedication were observed. DISCUSSION Shearer (1960 , 1961 , in a survey on the evolution of premedication, states that Schafer (1880) first suggested that atropine should be used before chloroform anaesthesia. He thought that death under chloroform was due to vagal stimulation. In Great Britain by 1900, the use of atropine was common practice in the belief that it prevented sudden death with chloroform. This was reinforced later by Embley (1902) , "Section of the Vagi or atropinization absolutely abolishes heart arrest under chloroform". But chloroform deaths continued. By 1915, the use of ether in preference to chloroform was widespread and the routine use of atropine before anaesthesia was suggested by Buxton. By 1920 it had become a routine. It was generally recognized that ether caused excessive production of secretions, easily prevented by a small dose of atropine which allowed smoother induction and maintenance of anaesthesia.
In the following years it became common for all adult patients to receive morphine 10 mg and atropine 0·6 mg or papaveretum 20 mg and hyoscine 0·4 mg as a standard premedication without any attempt to individualize the dose. With the passage of time and the introduction of relaxant drugs and halothane, many anaesthetists have felt the need to reassess the requirement for atropine premedication. Suggestions have been made that atropine need not be given as a routine premedication (Eger 1962 , Holt 1962 and two investigations in the American literature have supported this concept (Levy, Porter and Coakley 1964, Middleton, Zitzer and Urbach 1967) .
In the present study, using pethidine and promethazine without atropine as premedication in a selected group of patients, there was no significant increase in cardiac arrhythmias during the induction of anaesthesia. In two bronchitic patients only were secretions troublesome during induction. This is not statistically significant. Similarly, there was no statistical evidence of post-operative secretory problems or vomiting related to absence of atropine in premedication.
These results may have depended on the use of promethazine, which has some atropine-like effect, although this is not considered sufficient to be of therapeutic value. Promethazine does, however, have definite anti-emetic action (Goodman and Gilman 1970) .
The infrequent incidence of bradycardia during anaesthesia is effectively countered by the use of intravenous atropine. The hazard of intravenous atropine in anaesthesia is a matter of controversy and arrhythmias have been reported (Farman 1967 , Eger 1962 , lones, Deutsch and Turndorf 1961 .
The use of atropine premedication has not been shown to reduce the need for intravenous atropine during anaesthesia.
Old habits die hard. Many anaesthetists are conditioned to giving vagal blocking drugs prior to anaesthesia. This study suggests that atropine premedication is not of significant benefit in routine anaesthesia when using nonirritating agents. In selected cases atropine probably has a place; particularly in children, when factors such as the oculocardiac reflex (Pontinon 1966) and the vagal stimUlating effect of multiple doses of suxamethonium must be kept in mind. However, under these circumstances many would prefer to administer atropine intravenously in association with the induction of anaesthesia.
